U of M Study: Common Diabetes Drug Can Prevent Long COVID

(Minneapolis, MN) — A common drug used to treat diabetes has the power to prevent long COVID. A recent study led by researchers at the University of Minnesota found that Metformin lowers the risk of getting long COVID. The study revealed that overweight or obese people between the ages of 30- and 85-years-old who had COVID were about 40-percent less likely to develop long COVID if they took the drug. Participants who received Metformin were compared to participants who were given a placebo. The principal investigator said the drug is ” inexpensive, safe and widely available,”so this discovery could have “significant public health implications.”

More Stories

Today's Top Stories